434 results on '"van Wezel, Tom"'
Search Results
2. Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid
3. Germline variant affecting p53β isoforms predisposes to familial cancer
4. Enrichment of colibactin-associated mutational signatures in unexplained colorectal polyposis patients
5. Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas
6. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
7. Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics
8. MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome
9. Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development
10. Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors
11. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome–Associated Colorectal Carcinomas
12. Molecular functions of MCM8 and MCM9 and their associated pathologies
13. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study
14. The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis
15. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas
16. Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4
17. Author Correction: Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition
18. Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition
19. Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients
20. Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients
21. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype
22. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer
23. The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations
24. RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer
25. Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients
26. Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study.
27. Clinicopathological characteristics of glomeruloid architecture in prostate cancer
28. Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing
29. Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing
30. Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing
31. Declining detection rates for APC and biallelic MUTYH variants in polyposis patients, implications for DNA testing policy
32. HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic
33. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2
34. Targeted next generation sequencing screening of Lynch syndrome in Tunisian population
35. Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
36. Refinement of the associations between risk of colorectal cancer and polymorphisms on chromosomes 1q41 and 12q13.13
37. Tumour-guided cell free tumour DNA analysis in peritoneal fluids of gastric cancer patients can detect occult peritoneal metastases
38. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
39. “The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
40. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
41. SNP association study in PMS2-associated Lynch syndrome
42. RNA analysis of cancer predisposing genes in formalin-fixed paraffin-embedded tissue determines aberrant splicing
43. Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer
44. Differentiating Benign from Malignant Thyroid Tumors by Kinase Activity Profiling and Dabrafenib BRAF V600E Targeting.
45. A clinically applicable molecular classification of oncocytic cell thyroid nodules.
46. Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays
47. Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia
48. BRAFV600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis
49. Molecular Diagnostics for TP53 Is Recommended in B-Cell Lymphomas
50. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.